Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115353482B reveals metal-free synthesis for high-purity intermediates. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN115286578B reveals a metal-free route for trifluoromethyl pyrazoles. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112679431B reveals a novel atmospheric pressure method for isoquinolinone synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel Pd-catalyzed multi-component route eliminates toxic CO gas, offering cost-effective production of high-purity pharmaceutical intermediates with superior scalability.
Discover a green, one-pot synthesis for 4-aryl-4,5-dihydrofurans using K2CO3. Eliminate heavy metals and reduce costs for reliable pharmaceutical intermediate supply.
Patent CN118126005B enables metal-free synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates globally.
Novel Pd-catalyzed tandem reaction for quinolinone derivatives. Reduces steps, enhances supply chain reliability for pharma intermediates.
Patent CN118619879A details a novel Rhodium-catalyzed route for trifluoromethyl enaminones, offering high purity and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN107235967B reveals a green, mild synthesis of Tegafur using 5-fluorouracil and THF. Discover cost-effective manufacturing strategies for high-purity antineoplastic intermediates.
Novel Raney Nickel catalytic method reduces energy and solvent costs for pharmaceutical intermediate manufacturing supply chain efficiency and high purity output.
Novel metal-free route for trifluoromethyl 1,2,4-triazines. High yields, mild conditions, scalable process for API intermediates.
Novel Rh-catalyzed oxidative coupling method for 2-methylene-1-indanone derivatives. Offers high purity, simplified workflow, and cost-effective API intermediate manufacturing solutions.
Patent CN115286578B reveals metal-free synthesis enhancing purity and supply chain reliability for high-purity trifluoromethyl-containing pyrazole compound manufacturing processes globally.
Novel heterogeneous catalytic method for benzimidazole synthesis offering mild conditions and recyclable catalysts for cost-effective production.
Patent CN111285846B details a novel Rh-catalyzed C-H activation route for 2-(2-indolyl)-acetates, offering cost reduction and scalable manufacturing for pharma intermediates.
Patent CN118638038B reveals novel chiral isothiourea catalysis for high-purity indole amides. Enables cost reduction and scalable supply chain for pharmaceutical intermediates manufacturing.
Patent CN112125856A reveals a safe palladium-catalyzed route to 2-trifluoromethyl quinazolinones using solid CO surrogates, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN102060761B reveals a metal-free iodine-catalyzed route for quinoline derivatives, offering significant cost reduction and simplified purification for pharmaceutical intermediate manufacturing.
Patent CN116813544B reveals metal-free heating method for quinoline synthesis offering supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112920173A details a chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing for anticancer drug development.